| Literature DB >> 33527999 |
Fan Li1, Hengshi Yu2, Paul J Rathouz3, Elizabeth L Turner4, John S Preisser5.
Abstract
Stepped wedge cluster randomized trials (SW-CRTs) with binary outcomes are increasingly used in prevention and implementation studies. Marginal models represent a flexible tool for analyzing SW-CRTs with population-averaged interpretations, but the joint estimation of the mean and intraclass correlation coefficients (ICCs) can be computationally intensive due to large cluster-period sizes. Motivated by the need for marginal inference in SW-CRTs, we propose a simple and efficient estimating equations approach to analyze cluster-period means. We show that the quasi-score for the marginal mean defined from individual-level observations can be reformulated as the quasi-score for the same marginal mean defined from the cluster-period means. An additional mapping of the individual-level ICCs into correlations for the cluster-period means further provides a rigorous justification for the cluster-period approach. The proposed approach addresses a long-recognized computational burden associated with estimating equations defined based on individual-level observations, and enables fast point and interval estimation of the intervention effect and correlations. We further propose matrix-adjusted estimating equations to improve the finite-sample inference for ICCs. By providing a valid approach to estimate ICCs within the class of generalized linear models for correlated binary outcomes, this article operationalizes key recommendations from the CONSORT extension to SW-CRTs, including the reporting of ICCs. © The authors 2021. Published by Oxford University Press.Entities:
Keywords: Cluster randomized trials; Finite-sample correction; Generalized estimating equations; Intraclass correlation coefficient; Matrix-adjusted estimating equations (MAEE); Statistical efficiency
Mesh:
Year: 2022 PMID: 33527999 PMCID: PMC9291643 DOI: 10.1093/biostatistics/kxaa056
Source DB: PubMed Journal: Biostatistics ISSN: 1465-4644 Impact factor: 5.279